Emodin attenuates estrogen-deficient sarcopenia by suppressing CYP1B1 to restore CD36-driven fatty acid handling in muscle stem cells.

Sarcopenia is a progressive, estrogen-deficiency-related syndrome characterized by the loss of muscle mass and regenerative capacity, particularly in postmenopausal women. We identify Emodin, a natural anthraquinone compound, as a potent metabolic mo…

Preview only. Read the full abstract at the source